GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (MIL:PHIL) » Definitions » Return-on-Tangible-Asset

Philogen SpA (MIL:PHIL) Return-on-Tangible-Asset : 89.80% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Philogen SpA's annualized Net Income for the quarter that ended in Dec. 2024 was €121.62 Mil. Philogen SpA's average total tangible assets for the quarter that ended in Dec. 2024 was €135.43 Mil. Therefore, Philogen SpA's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 was 89.80%.

The historical rank and industry rank for Philogen SpA's Return-on-Tangible-Asset or its related term are showing as below:

MIL:PHIL' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -15.72   Med: -5.08   Max: 34.94
Current: 34.94

During the past 5 years, Philogen SpA's highest Return-on-Tangible-Asset was 34.94%. The lowest was -15.72%. And the median was -5.08%.

MIL:PHIL's Return-on-Tangible-Asset is ranked better than
97.93% of 1495 companies
in the Biotechnology industry
Industry Median: -36.98 vs MIL:PHIL: 34.94

Philogen SpA Return-on-Tangible-Asset Historical Data

The historical data trend for Philogen SpA's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Return-on-Tangible-Asset Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Asset
-15.72 -14.54 -4.19 -5.08 31.75

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.29 11.88 -21.99 -28.01 89.80

Competitive Comparison of Philogen SpA's Return-on-Tangible-Asset

For the Biotechnology subindustry, Philogen SpA's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philogen SpA's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Philogen SpA's Return-on-Tangible-Asset falls into.


;
;

Philogen SpA Return-on-Tangible-Asset Calculation

Philogen SpA's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=45.292/( (118.024+167.293)/ 2 )
=45.292/142.6585
=31.75 %

Philogen SpA's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=121.616/( (103.558+167.293)/ 2 )
=121.616/135.4255
=89.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2024) net income data.


Philogen SpA  (MIL:PHIL) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Philogen SpA Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

From GuruFocus

PHI Group, Inc. Acquires Majority Interest in Tin Thanh Group

By GlobeNewswire GlobeNewswire 08-19-2022

PHI Group, Inc. Acquires Majority Interest in Tin Thanh Group

By PurpleRose PurpleRose 08-19-2022